News & Views

Adobestock 550344920

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

Expanded agreement grants Iksuda access to Legochem Biosciences’ next generation ADC platform for up to six targets

Sign up for more news

Thank you
*required field
*required field
*required field
I confirm that I have read the data protection and Privacy Policy and that I agree to the processing of my personal data